To access the localized content, select the website associated with the Division of your interest:

Health & Safety

    Healthcare & Life Sciences

      Energy & Mobility

        Investor Relations

        Press Releases

        Press releases

        1. GVS approves consolidated results to 30 June 2021 revenues up 29.7%, EBITDA margin at 37.9%
          Price Sensitive
        2. GVS acquires 100% of the RPB Group, an American player specialised in the design and production of respiratory protection devices, and completes its product range in the world of professional masks.
          Price Sensitive
        3. GVS approves consolidated results as at 31 March 2021
          Price Sensitive
        4. The GVS Board of Directors approves the 2020 financial statement: revenues up 60%, strong growth in Group profitability and solid increase in all key economic and financial indicators
          Price Sensitive
        5. GVS S.p.A. – Financial Calendar 2021
          Price Sensitive

        1. GVS approves the consolidated results at 30 September 2020 revenue up 49.6% and marked growth of the Group’s profit margin.
          Price Sensitive
        2. The bod of GVS S.p.A. Approves the first half 2020 results revenue at 30 june 2020 up 25% and considerable growth in profit margin.
          Price Sensitive
        3. GVS: completion of the Closing of the acquisition of Haemonetics Puerto Rico, LLC,
          Price Sensitive
        4. GVS S.p.A. – Financial Calendar 2020.
          Price Sensitive
        5. GVS announces the agreement to acquire Puerto Rico-based manufacturing operations of Haemonetics.

        This website uses first-party and third-party cookies in order to offer dynamic content and a better user experience. For further information please read our Privacy Policy.